West Virginia University Center for Neuroscience

[2008]

El-Fawal HA, O'Callaghan JP. Autoantibodies to neurotypic and gliotypic proteins as biomarkers of neurotoxicity: assessment of trimethyltin (TMT). Neurotoxicology (2008), 29(1):109-115.
Fox DA, Kala SV, Hamilton WR, Johnson JE, O'Callaghan JP. Low-level human equivalent gestational lead exposure produces supernormal scotopic electroretinograms, increased retinal neurogenesis, and decreased retinal dopamine utilization in rats. Environmental Health Perspectives (2008), 116(5):618-25.
Scharf MT, Mackiewicz M, Naidoo N, O'Callaghan JP, Pack AI. AMP-activated protein kinase phosphorylation in brain is dependent on method of killing and tissue preparation. Journal of Neurochemistry (2008), 105(3):833-841.
Zin CS, Nissen LM, Smith MT, O'Callaghan JP, Moore BJ. An update on the pharmacological management of post-herpetic neuralgia and painful diabetic neuropathy. CNS Drugs (2008), 22(5):417-442.

[2007]

Berman JW, Carson MJ, Chang L, Cox BM, Fox HS, Gonzalez RG, Hanson GR, Hauser KF, Ho W, Hong J, Major E, Maragos WF, Masliah E, McArthur JC, Miller DB, Nath A, O'Callaghan JP, Persidsky Y, Power C, Rogers TJ, Royal W. NeuroAIDS, drug abuse, and inflammation: building collaborative research activities. Journal of Neuroimmune Pharmacology (2006), 1(4):351-399.
Bowyer JF, Pogge AR, Delongchamp RR, O'Callaghan JP, Patel KM, Vrana KE, Freeman WM. A threshold neurotoxic amphetamine exposure inhibits parietal cortex expression of synaptic plasticity-related genes. Neuroscience (2007), 144(1):66-76.
Damiani CL, O'Callaghan JP. Recapitulation of cell signaling events associated with astrogliosis using the brain slice preparation. Journal of Neurochemistry (2007), 100(3):720-726.
Hubbs AF, Benkovic SA, Miller DB, O'Callaghan JP, Battelli L, Schwegler-Berry D, Ma Q. Vacuolar leukoencephalopathy with widespread astrogliosis in mice lacking transcription factor Nrf2. American Journal of Pathology (2007), 170(6):2068-2076.
Schulte PA, Wagner GR, Ostry A, Blanciforti LA, Cutlip RG, Krajnak KM, Luster M, Munson AE, O'Callaghan JP, Parks CG, Simeonova PP, Miller DB. Work, obesity, and occupational safety and health. American Journal of Public Health (2007), 97(3):428-436.
Sriram K, O'Callaghan JP. Divergent roles for tumor necrosis factor-α in the brain. Journal of Neuroimmune Pharmacology (2007), 2(2):140-153.

[2006]

Antonini JM, O'Callaghan JP, Miller DB. Development of an animal model to study the potential neurotoxic effects associated with welding fume inhalation. Neurotoxicology (2006), 27(5):745-751.
Benkovic SA, O'Callaghan JP, Miller DB. Regional neuropathology following kainic acid intoxication in adult and aged C57BL/6J mice. Brain Research (2006), 1070(1):215-231.
Little AR, Sriram K, O'Callaghan JP. Corticosterone regulates expression of CCL2 in the intact and chemically injured hippocampus. Neuroscience Letters (2006), 399(1-2):162-166.
Miller DB, O'Callaghan JP. The pharmacology of wakefulness. Metabolism (2006), 55(10Suppl2):S13-19.
Reed MD, Blair LF, Burling K, Daly I, Gigliotti AP, Gudi R, Mercieca MD, McDonald JD, O'Callaghan JP, Seilkop SK, Ronskoh NL, Wagner VO, Kraska RC. Health effects of subchronic exposure to diesel-water-methanol emulsion emission. Toxicology & Industrial Health (2006), 22(2):65-85.
Sriram K, Matheson JM, Benkovic SA, Miller DB, Luster MI, O'Callaghan JP. Deficiency of TNF receptors suppresses microglial activation and alters the susceptibility of brain regions to MPTP-induced neurotoxicity: role of TNF-alpha. FASEB Journal (2006), 20(6):670-682.
Sriram K, Miller DB, O'Callaghan JP. Minocycline attenuates microglial activation but fails to mitigate striatal dopaminergic neurotoxicity: role of tumor necrosis factor-alpha. Journal of Neurochemistry (2006), 96(3):706-718.
Wei H, Nolkrantz K, Parkin MC, Chisolm CN, O'Callaghan JP, Kennedy RT. Identification and quantification of neuropeptides in brain tissue by capillary liquid chromatography coupled off-line to MALDI-TOF and MALDI-TOF/TOF-MS. Analytical Chemistry (2006), 78(13):4342-4351.

[2005]

de Groot DM, Hartgring S, van de Horst L, Moerkens M, Otto M, Bos-Kuijpers MH, Kaufmann WS, Lammers JH, O'Callaghan JP, Waalkens-Berendsen ID, Pakkenberg B, Gundersen HG. 2D and 3D assessment of neuropathology in rat brain after prenatal exposure to methylazoxymethanol, a model for developmental neurotoxicty. Reproductive Toxicology(2005), 20(3):417-432.
Miller DB, O'Callaghan JP. Aging, stress, and the hippocampus. Aging Research Reviews (2005), 4(2):123-140.
Miller DB, O'Callaghan JP. Depression, cytokines, and glial function. Metabolism (2005), 54(5Suppl_1):33-38.
O'Callaghan JP, Sriram K. Glial fibrillary acidic protein and related glial proteins as biomarkers of neurotoxicity. Expert Opinion on Drug Safety (2005), 4(3):433-442.
Parkin MC, Wei H, O'Callaghan JP, Kennedy RT. Sample-dependent effects on the neuropeptidome detected in rat brain tissue preparations by capillary liquid chromatography with tandem mass spectrometry. Analytical Chemisty (2005), 77(19):6331-6338.
Reed MD, Blair LF, Burling K, Daly I, Gigliotti AP, Gudi R, Mercieca MD, McDonald JD, Naas DJ, O'Callaghan JP, Seilkop SK, Ronsko NL, Wagner VO, Kraska RC. Health effects of subchronic exposure to diesel-water emulsion emission. Inhalation Toxicology (2005), 17(14):851-870.
Toscano CD, O'Callaghan JP, Guilarte TR. Calcium/calmodulin-dependent protein kinase II activity and expression are altered in the hippocampus of Pb2+-exposed rats. Brain Research (2005), 1044(1):51-58.
Wei H, Dean SL, Parkin MC, Nolkrantz K, O'Callaghan JP, Kennedy RT. Microscale sample deposition onto hydrophobic target plates for trace level detection of neuropeptides in brain tissue by MALDI-MS. Journal of Mass Spectrometry (2005), 40(10):1338-1346.

[2004]

Benkovic SA, O'Callaghan JP, Miller DB. Sensitive indicators of injury reveal hippocampal damage in C57BL/6J mice treated with kainic acid in the absence of tonic-clonic seizures. Brain Research (2004), 1024(1-2):59-76.
Bowyer JF, Harris AJ, Delongchamp RR, Jakab RL, Miller DB, Little AR, O'Callaghan JP. Selective changes in gene expression in cortical regions sensitive to amphetamine during the neurodegenerative process. Neurotoxicology (2004), 25(4):555-572.
Johnson EA, O'Callaghan JP, Miller DB. Brain concentrations of d-MDMA are increased after stress. Psychopharmacology (2004), 173(3-4):278-286.
Kashon ML, Ross GW, O'Callaghan JP, Miller DB, Petrovitch H, Burchfiel CM, Sharp DS, Markesbery WR, Davis DG, Hardman J, Nelson J, White LR. Associations of cortical astrogliosis with cognitive performance and dementia status. Journal of Alzheimer's Disease (2004), 6(6):595-604; discussion 673-681.
O'Callaghan JP, Sriram K. Focused microwave irradiation of the brain preserves in vivo protein phosphorylation: comparison with other methods of sacrifice and analysis of multiple phosphoproteins. Journal of Neuroscience Methods (2004), 135(1-2):159-168.
Sriram K, Benkovic SA, Hebert MA, Miller DB, O'Callaghan JP. Induction of gp130-related cytokines and activation of JAK2/STAT3 pathway in astrocytes precedes up-regulation of glial fibrillary acidic protein in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of neurodegeneration: key signaling pathway for astrogliosis in vivo? Journal of Biological Chemistry (2004), 279(19):19936-19947.